383 related articles for article (PubMed ID: 31575661)
1. Reactive oxygen species (ROS) generation is stimulated by κ opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation.
Schattauer SS; Bedini A; Summers F; Reilly-Treat A; Andrews MM; Land BB; Chavkin C
J Biol Chem; 2019 Nov; 294(45):16884-16896. PubMed ID: 31575661
[TBL] [Abstract][Full Text] [Related]
2. G alpha 12/13- and reactive oxygen species-dependent activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase by angiotensin receptor stimulation in rat neonatal cardiomyocytes.
Nishida M; Tanabe S; Maruyama Y; Mangmool S; Urayama K; Nagamatsu Y; Takagahara S; Turner JH; Kozasa T; Kobayashi H; Sato Y; Kawanishi T; Inoue R; Nagao T; Kurose H
J Biol Chem; 2005 May; 280(18):18434-41. PubMed ID: 15743761
[TBL] [Abstract][Full Text] [Related]
3. Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes.
Bruchas MR; Macey TA; Lowe JD; Chavkin C
J Biol Chem; 2006 Jun; 281(26):18081-9. PubMed ID: 16648139
[TBL] [Abstract][Full Text] [Related]
4. Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.
Schattauer SS; Kuhar JR; Song A; Chavkin C
Cell Signal; 2017 Apr; 32():59-65. PubMed ID: 28088389
[TBL] [Abstract][Full Text] [Related]
5. Ligand directed signaling differences between rodent and human κ-opioid receptors.
Schattauer SS; Miyatake M; Shankar H; Zietz C; Levin JR; Liu-Chen LY; Gurevich VV; Rieder MJ; Chavkin C
J Biol Chem; 2012 Dec; 287(50):41595-607. PubMed ID: 23086943
[TBL] [Abstract][Full Text] [Related]
6. Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria.
Bruchas MR; Land BB; Aita M; Xu M; Barot SK; Li S; Chavkin C
J Neurosci; 2007 Oct; 27(43):11614-23. PubMed ID: 17959804
[TBL] [Abstract][Full Text] [Related]
7. The orexin 1 receptor modulates kappa opioid receptor function via a JNK-dependent mechanism.
Robinson JD; McDonald PH
Cell Signal; 2015 Jul; 27(7):1449-56. PubMed ID: 25857454
[TBL] [Abstract][Full Text] [Related]
8. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
[TBL] [Abstract][Full Text] [Related]
9. Peroxiredoxin 6 mediates Gαi protein-coupled receptor inactivation by cJun kinase.
Schattauer SS; Land BB; Reichard KL; Abraham AD; Burgeno LM; Kuhar JR; Phillips PEM; Ong SE; Chavkin C
Nat Commun; 2017 Sep; 8(1):743. PubMed ID: 28963507
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Reduction of Kappa Opioid Receptor Function by the Biased Ligand, Norbinaltorphimine, Requires c-Jun N-Terminal Kinase Activity and New Protein Synthesis in Peripheral Sensory Neurons.
Jamshidi RJ; Sullivan LC; Jacobs BA; Chavera TA; Berg KA; Clarke WP
J Pharmacol Exp Ther; 2016 Nov; 359(2):319-328. PubMed ID: 27605628
[TBL] [Abstract][Full Text] [Related]
11. Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase.
Bruchas MR; Yang T; Schreiber S; Defino M; Kwan SC; Li S; Chavkin C
J Biol Chem; 2007 Oct; 282(41):29803-11. PubMed ID: 17702750
[TBL] [Abstract][Full Text] [Related]
12. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
[TBL] [Abstract][Full Text] [Related]
13. Kinase cascades and ligand-directed signaling at the kappa opioid receptor.
Bruchas MR; Chavkin C
Psychopharmacology (Berl); 2010 Jun; 210(2):137-47. PubMed ID: 20401607
[TBL] [Abstract][Full Text] [Related]
14. Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase.
Xu M; Bruchas MR; Ippolito DL; Gendron L; Chavkin C
J Neurosci; 2007 Mar; 27(10):2570-81. PubMed ID: 17344394
[TBL] [Abstract][Full Text] [Related]
15. Signaling events initiated by kappa opioid receptor activation: quantification and immunocolocalization using phospho-selective KOR, p38 MAPK, and K(IR) 3.1 antibodies.
Lemos JC; Roth CA; Chavkin C
Methods Mol Biol; 2011; 717():197-219. PubMed ID: 21370032
[TBL] [Abstract][Full Text] [Related]
16. D1 dopamine receptor agonists mediate activation of p38 mitogen-activated protein kinase and c-Jun amino-terminal kinase by a protein kinase A-dependent mechanism in SK-N-MC human neuroblastoma cells.
Zhen X; Uryu K; Wang HY; Friedman E
Mol Pharmacol; 1998 Sep; 54(3):453-8. PubMed ID: 9730903
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Kappa Opioid Receptor Inactivation Depends on Sex and Cellular Site of Antagonist Action.
Reichard KL; Newton KA; Rivera ZMG; Sotero de Menezes PM; Schattauer SS; Land BB; Chavkin C
Mol Pharmacol; 2020 Nov; 98(5):548-558. PubMed ID: 32913138
[TBL] [Abstract][Full Text] [Related]
18. Olaquindox-induced apoptosis is suppressed through p38 MAPK and ROS-mediated JNK pathways in HepG2 cells.
Zhao WX; Tang SS; Jin X; Zhang CM; Zhang T; Wang CC; Sun Y; Xiao XL
Cell Biol Toxicol; 2013 Aug; 29(4):229-38. PubMed ID: 23812630
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation of Kir3 following kappa-opioid receptor activation of p38 MAPK causes heterologous desensitization.
Clayton CC; Xu M; Chavkin C
J Biol Chem; 2009 Nov; 284(46):31872-81. PubMed ID: 19773548
[TBL] [Abstract][Full Text] [Related]
20. Arrestin regulates MAPK activation and prevents NADPH oxidase-dependent death of cells expressing CXCR2.
Zhao M; Wimmer A; Trieu K; Discipio RG; Schraufstatter IU
J Biol Chem; 2004 Nov; 279(47):49259-67. PubMed ID: 15364949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
